Increase in biomarker linked with increased risk of heart disease, heart failure, deathJune 08, 2016
In a study published online by JAMA Cardiology, Elizabeth Selvin, Ph.D., M.P.H., of the Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues examined the association of 6-year change in high-sensitivity cardiac troponin T with incident coronary heart disease, heart failure and all-cause mortality.
High-sensitivity cardiac troponin T (hs-cTnT), a protein that can be measured via a blood test, is a biomarker of cardiovascular risk and could be approved in the United States for clinical use soon. Cardiac troponin is critical to the clinical diagnosis of heart attack, particularly among symptomatic persons with chest pain. However, little is known about the implications of changes in hs-cTnT levels over time. This analysis included 8,838 participants from the Atherosclerosis Risk in Communities Study who were initially free of coronary heart disease (CHD) and heart failure (HF) and who had hs-cTnT measured twice, 6 years apart.
Of the participants (average age, 56 years; 59 percent female; 21 percent black), there were 1,157 CHD events, 965 HF events, and 1,813 deaths overall. Incident detectable hs-cTnT (baseline, <0.005 ng/ml; follow-up, ? 0.005 ng/ml) was independently associated with subsequent CHD, HF and death relative to an hs-cTnT level less than 0.005 ng/ml at both visits. Individuals with the most marked hs-cTnT increases (e.g. baseline, < 0.005 ng/ml; follow-up, ? 0.014 ng/ml) had significantly increased risks for CHD, HF and death. In persons with decreasing hs-cTnT levels (e.g., 6-year reductions >50 percent from baseline), there was also evidence suggestive of lower risk for outcomes compared with persons with stable or increasing concentrations.
"Our results indicate that 2 measurements of hs-cTnT appear to be better than 1 for characterizing risk and that large increases in hs-cTnT are particularly deleterious. Temporal change in hs-cTnT may help guide the preventive management of asymptomatic persons at risk for CHD and adults with stage A or B HF," the authors write.
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Note: An accompanying commentary, "Biomarkers to Predict Risk in Apparently Well Populations," by James L. Januzzi Jr., M.D., of Massachusetts General Hospital, Boston, is available pre-embargo at the For The Media website.
Media Advisory: To contact co-author John W. McEvoy, M.B., B.Ch., M.H.S., call Vanessa McMains at 410-502-9410 or email email@example.com.
The JAMA Network Journals
Related Heart Failure Articles:
Heart failure patients who are getting by on existing drug therapies can look forward to a far more effective medicine in the next five years or so, thanks to University of Alberta researchers.
Chronic inflammation after a heart attack can promote heart failure and death.
Does a stay in the intensive care unit give patients a better chance of surviving a chronic obstructive pulmonary disease (COPD) or heart failure flare-up or even a heart attack, compared with care in another type of hospital unit?
Researchers have grown heart tissue by seeding a mix of human cells onto a 1-micron-resolution scaffold made with a 3-D printer.
Smokers without obvious signs of heart disease were more likely than nonsmokers and former smokers to have thickened heart walls and reduced heart pumping ability.
During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells in the heart.
People who develop heart failure after their first heart attack have a greater risk of developing cancer when compared to first-time heart attack survivors without heart failure, according to a study today in the Journal of the American College of Cardiology.
A team of researchers have created a detailed computational model of the electrophysiology of congestive heart failure, a leading cause of death.
In a study published online by JAMA Cardiology, Elizabeth Selvin, Ph.D., M.P.H., of the Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues examined the association of six-year change in high-sensitivity cardiac troponin T with incident coronary heart disease, heart failure and all-cause mortality.
One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25,000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure by Dr.
Related Heart Failure Reading:
Heart Failure: A Companion to Braunwald's Heart Disease, 3e
by Douglas L. Mann MD (Author), G. Michael Felker MD MHS FACC FAHA (Author)
Lead editor of Braunwald’s Heart Disease, Dr. Douglas L. Mann, and nationally and internationally recognized heart failure expert Dr. G. Michael Felker, bring you the latest, definitive state-of-the art information on heart failure in this outstanding Braunwald’s companion volume. Heart Failure, 3rd Edition, keeps you current with recent developments in the field, improved patient management strategies, and new drug therapies and implantable devices that will make a difference in your patients’ lives and in your practice. Braunwald’s Heart Failure... View Details
by Richard Mabry (Author)
When her fiancé’s dangerous secrets turn her work upside down, a beautiful doctor must choose between her own safety and the man she loves—and thought she knew.
Dr. Carrie Markham’s heart was broken by the death of her husband two years ago. Now, just as her medical practice is taking off, her fresh engagement to paralegal Adam Davidson seems almost too good to be true . . . until a drive-by shooting leaves Carrie on the floor of his car with glass falling around her.
When he confesses that Adam isn’t his real name and that he fled the witness protection program,... View Details
Heart Failure Pocketcard Set
by M.D. Szady (Author), M.D. Bavry (Author)
Heart Failure: A Practical Guide for Diagnosis and Management (Oxford American Cardiology Library)
by Stuart Katz (Author), Ragavendra Baliga (Series Editor)
Clinical practice consensus guidelines for management of heart failure are available from the American Heart Association/American College of Cardiology, Heart Failure Society of America, Canadian Cardiovascular Society, and European Society of Cardiology. The guidelines from these organizations, based on evidence from clinical trials and expert agreement, are largely concordant and provide useful information for practitioners. Yet, the organization of the guidelines may confound efforts by a practitioner to determine which specific intervention, or combination of interventions, are most... View Details
Heart Failure Recovery: Complete Failure to Complete Recovery
by Ray Reynolds (Author)
”Our knowledge of human biology doubles every four years.” This makes it nearly impossible for physicians to stay current on the latest research in their own fields let alone in all of the others that directly effect their ability to properly treat their patients. In this new book by Bio Researcher Ray Reynolds you will learn... How heart muscle cells have the ability to stay alive by hibernating when deprived of oxygen. The four nutriants needed to revive them after the coranary artery blockage has been removed. How to utilize minimum effective doses of heart medications to regulate... View Details
Oxford Textbook of Advanced Heart Failure and Cardiac Transplantation
by Michael Domanski (Editor), Mandeep R. Mehra (Editor), Marc Pfeffer (Editor)
Heart failure is epidemic throughout the world. A growing incidence and prevalence has resulted in a large population of individuals transitioning to advanced stages of the syndrome and requiring uniquely specialised therapies and cardiac transplantation.
Oxford Textbook of Advanced Heart Failure and Cardiac Transplantation is a focused and comprehensive work covering this new and rapidly growing cardiovascular subspecialty. Authored by eminent international experts, it is the authoritative text on advanced heart failure and a central resource for clinicians caring for patients with... View Details
Living Well with Heart Failure, the Misnamed, Misunderstood Condition
by Edward K. Kasper (Author), Mary Knudson (Author)
Heart failure―the expression alone is scary. The idea that the blood-pumping organ in our chest can struggle, stutter, or suddenly stop is deeply disconcerting. But for those who get the diagnosis, the future is not necessarily bleak. With the right treatments and a healthy lifestyle that includes exercise and good nutrition, many people with heart failure can improve their condition and live well.
Heart failure expert Edward K. Kasper, M.D., teams with journalist―and survivor―Mary Knudson to give readers an honest account of this misunderstood condition. The authors... View Details
Heart Failure: A Comprehensive Guide to Pathophysiology and Clinical Care
by Howard Eisen (Editor)
This comprehensively covers everything from pathophysiology to the evaluation of patients presenting with heart failure to medical management, device therapy, heart transplantation and mechanical circulatory support, and include relevant cardiac imaging studies such as echocardiograms and magnetic resonance imaging studies which could be seen in their entirety as well as pathology slides, hemodynamic tracings and videos of cardiac surgery such as heart transplants and ventricular assist device implantation. Finally, the book would have videos of patients with heart failure, heart transplants... View Details
The 4 Stages of Heart Failure
by Brian Jaski (Author)
If you understand heart failure, you understand cardiology This book applies practical clinical concepts to the latest four-stage model of heart failure from preclinical risk and early asymptomatic disease to classic symptomatic heart failure and finally advanced heart failure. This framework emphasizes a tailored approach to ongoing heart failure assessment to guide therapy and improve outcomes. View Details
I Think I Need a New Heart: The Journey from Heart Failure to Transplant
by Manu Kalia (Author)
A frank and honest account of one patient's journey: from end-stage congestive heart failure, to artificial heart-assist-pump implantation, and eventually, to heart transplantation, recovery, and health. This memoir shares a first-hand perspective of the fears, challenges, and joys of facing a life-threatening illness, and being given the gift of a second chance at life. For all those who face organ failure and transplantation, for their loved ones, for those who work in the transplant healthcare arena, and for organ donors and their families. View Details